31
CHYLOTHORAX By DR.VIJAYANAND PALANISAMY

Chylothorax

Embed Size (px)

Citation preview

Page 1: Chylothorax

CHYLOTHORAX

By DR.VIJAYANAND PALANISAMY

Page 2: Chylothorax

Thoracic duct

- Is the largest lymphatic trunk which drains chyle(product of fat digestion) & most lymph of body.

- Extent- Upper abdomen at lower border of T12 to lower part of neck, crossing post & sup mediastinum

- 45cms long & 0.5cms wide

- Appears Beaded due to presence of many valves in its lumen

2

Page 3: Chylothorax

Drains lymph from whole of body except • Rt side of head & neck

• Rt upper limb

• Rt lung & thoracic wall

• Rt side of heart and rt surface of liver

AREA OF DRAINAGE

3

Page 4: Chylothorax
Page 5: Chylothorax

COURSE:

* BEGINS IN ABDOMEN AT LOWER BORDER OF T12 AS A CONTINUATION OF CISTERNA CHYLI

* ENTERS POST MEDIASTINUM THROUGH AORTIC OPENING OF DIAPHRAGM(T12)

* AT T5 SHIFTS TO LEFT & RUNS IN SUPERIOR MEDIASTINUM

* AT C7 (ROOT OF NECK) ARCHES LATERALLY, THEN DOWNWARDS

* ENDS AT ANGLE FORMED BY UNION OF LEFT INT JUGULAR VEIN & LT SUBCLAVIAN VEIN, (REGURGE OF BLOOD PREVENTED BY A PAIR OF VALVES)

Page 6: Chylothorax

COMPOSITION OF CHYLE

Lipids - 60% to 70% of ingested fat absorbed by intestinal lymphatics.

Proteins Electrolytes Cellular Elements Miscellaneous Elements - Fat soluble

vitamins, antibodies, urea nitrogen, and enzymes

Page 7: Chylothorax

CHYLOTHORAX A chylothorax (or chyle leak) is a type of

pleural effusion. It results from lymph formed in the digestive system called chyle accumulating in the pleural cavity due to either disruption or obstruction of the thoracic duct.

In a normal adult, the thoracic duct transports up to 4 L of chyle per day, allowing a rapid and large accumulation of fluid in the chest

The prevalence after various cardiothoracic surgeries is 0.2-1%.

Page 8: Chylothorax

CHYLOMA a collection of chyle below the pleura

develops when the thoracic duct first leaks severe chest pain, dyspnoea and tachycardia

Page 9: Chylothorax

AETIOLOGY

Page 10: Chylothorax

subclavian vein catheterisation and duct blockage due to central venous catheterisation related venous thrombosis

Yellow nail syndrome-bronchiectasis, sinusitis , hypoplastic lymphatics, yellow nails (due to slow growth), lymphoedema, particularly of the lower limbs and pleural effusions

Page 11: Chylothorax

SIGNS AND SYMPTOMS Hypovolaemia Respiratory difficulty malnutrition due to the loss of protein, fats

and vitamins - weight loss and muscle wasting

hyponatraemia and hypocalcaemia Immunosuppression Empyema is a rare due to bacteriostatic

nature of lecithin and fatty acids Decreased breath sounds Shifting dullness

Page 12: Chylothorax

Congenital Chylothorax-Fluid initially clear but turns turbid with milk feeding

Page 13: Chylothorax

The effusion may be unilateral, either right (50%) or left sided (33.3%), or bilateral (16.66%) and is dependent on the location of the leak. Damage to the duct above the fifth thoracic vertebra results in a left sided effusion whereas damage to the duct below this level leads to a right sided effusion

Page 14: Chylothorax

INVESTIGATION confirmation of the diagnosis by fluid

analysis identification of the leakage point Investigation should continue until the

aetiology

Page 15: Chylothorax

fluid will not always be milky or white and may for example be blood stained after trauma or even serious in appearance if the patient is fasting

Collecting the fluid into an EDTA tube allows for cell counts on the sample.

Page 16: Chylothorax

thoracentesis and laboratory analysis of the pleural fluid

centrifugation of pleural fluid adding 1-2 ml of ethylether fluid stained with Sudan III

Page 18: Chylothorax

CT abdomen and thorax

Lymphangiograph

High fat content feed mixed with methylene blue

Page 19: Chylothorax

BIOCHEMICAL DIAGNOSIS OF CHYLOTHORAX pleural fluid triglyceride of >110 mg/dl had a

1% chance of being non-chylous and that a triglyceride of <50 mg/dl had a 5% chance of being chylous.

As a result, pleural fluid triglyceride levels>1.24 mmol/l (110 mg/dl) with a cholesterol<5.18 mmol/l (200 mg/dl) is diagnostic of chylothorax

Page 20: Chylothorax

PSEUDOCHYLOTHORAX tuberculous pleurisy, chronic pneumothorax,

rheumatoid pleurisy, poorly evacuated empyema and chronic haemothorax

Page 22: Chylothorax

Treatment is initially conservative:1. Tube drainage.2. Medium-chain fatty acid diet.3. Fluid and electrolyte support.4. NPO and TPN5. Somatostatin

Failure of conservative treatment requires surgical solution

Page 23: Chylothorax

OPERATIVE TECHNIQUES

Direct ligation of thoracic duct Supradiaphragmatic mass ligation of the

thoracic duct Video Assisted Thoracic Surgery (VATS) Pleurodesis�� Fibrin glue

Page 24: Chylothorax

DIAGNOSTIC CONSIDERATIONS

Timing of surgical management is controversial and depends on the etiology of the chylothorax and the patient's overall condition.

Patients with postesophagectomy chylothorax have a 50-82% mortality rate if treated conservatively.

A malignant etiology of the chylothorax must be ruled out, as greater than 50% of cases are due to malignancy, of which lymphoma accounts for approximately 75% of cases, followed by lung carcinoma.

Page 25: Chylothorax

ETIOLOGICAL TREATMENT sarcoidosis with steroids cardiac failure with diuretics Malignancy with radiotherapy or

chemotherapy if no improvement then pleurodesis

Page 26: Chylothorax

If the leak is in the region of the neck or upper thorax, the thoracic duct is ligated in the area known as Poirier’s triangle between the arch of the aorta, internal carotid and vertebral column

Page 27: Chylothorax

Ligation of the thoracic duct is successful in 90% of patients when performed just above the right hemi-diaphragm

Page 28: Chylothorax

VATS FOR LIGATION OF THORACIC DUCT

Page 29: Chylothorax

THORACIC DUCT EMBOLIZATION-EMBOLIZATION PERFORMED BY COILS AND GELATIN SPONGE

Page 30: Chylothorax

too unfit for major surgery or have malignancy, a pleuroperitoneal shunt may be useful . complications such as infection, adhesions, and clogging of the implants

1% Evans blue dye can either be injected into the web space of the toes for uptake into the lymphatic space to increase visualization.